Value sets
The EuroQol Office supports users in their research efforts. This page contains a set of tools that may be used for analysing EQ-5D data. These tools are sometimes the result of work conducted at the EuroQol Office, and other times the result of work conducted by research teams across the globe*.
Tools are available for the EQ-5D-5L, the EQ-5D-3L and the EQ-5D-Y-3L*. Examples of tools are value set calculators and cross–walk mappings to obtain EQ-5D-5L health state utility values when only the EQ-5D-3L tariffs exists.
If you wish to select the most appropriate tool for obtaining index values, please check our frequently asked questions. Please use one of the generic tools if the tool for the analysis of EQ-5D instruments you are interested in is not available. If you still need support, please use the Support form.
* At present, value sets for the EQ-5D-Y-5L are not available. The EuroQol Group is currently working on a protocol for the valuation of EQ-5D-Y-5L health states as well as a crosswalk function, which will allow users to link individual responses on the EQ-5D-Y-5L descriptive system with existing for the EQ-5D-Y-3L value sets.
Watch the video below
* Disclaimer: Whilst the EQ Foundation and EQ Office make its outmost effort in presenting accurate and up-to-date tools, the EQ Foundation and EQ Office make no representation or warranty on the correctness, adequacy, accuracy and completeness of the tools presented here, nor do warrant that the tools shall be complete in every respect. The EQ Foundation and EQ Office shall have no responsibility nor liability resulting from the use of these tools, nor for the absence of information on the site, which results in misuse thereof.
(Use the filter buttons below to quickly find the version(s) you need.)
(*) NICE does not recommend using this 5L value set for England for NICE technology appraisal submissions. EuroQol, in partnership with NICE, the Department of Health and Social Care and NHS England is currently developing a new EQ-5D-5L value set for the UK.